Work

Figure S1 from RAS Pathway Inhibitors Combined with Targeted Agents Are Active in Patient-Derived Spheroids with Oncogenic KRAS Variants from Multiple Cancer Types

Year: 2025
Type: other
Abstract: Figure S1. Response to sotorasib by multicell-type tumor spheroid models.
Language: English
Open Access status: gold
OpenAlex ID: W7085583017
Cites:
Cited by:
Related to: